ConCallIQ
Go Pro
FABTECH Diversified 14 Feb 2026

Fabtech Technologies Limited — Q3 FY26

Fabtech Technologies reported a soft Q3 FY26 due to timing issues, with ~20.3 crores of material at port deferred to Q4.

neutral medium
Compare with...
Revenue ₹63 Cr
EBITDA
PAT ₹-6 Cr
EBITDA Margin
Duration 68 min
Read Time 1 min read

✓ Verified against BSE filing

2-Minute Summary

✦ AI-Generated from Full Transcript

Fabtech Technologies reported a soft Q3 FY26 due to timing issues, with ~20.3 crores of material at port deferred to Q4. Revenue recognition is shipment-based, causing quarterly fluctuations. The order book stands at 926 crores as of Jan 31, 2026, with a healthy pipeline of $455 million in hot leads. Management maintained annual guidance of 380-400 crores revenue and 39-41 crores PAT, implying a strong Q4. The company is expanding into high-value segments like cell & gene therapy and animal health, and plans European acquisitions to boost win rates from 15% to 20-25%. A key risk is continued quarterly volatility due to revenue recognition policy, which management is reviewing but not yet changing.

Risks3 trackedTranscriptfull text
Research workspace

Focused Modules

!Risks 3 risks

Risk Intelligence

Quarterly Revenue Volatility

View Risks →
Transcript Full text

Call Transcript

Full transcript text is available on this route.

Read Transcript →

Quarter Snapshot

Order Book 926 Cr
N/A

Outstanding order book as of Jan 31, 2026, up from November 2025 levels.

Hot Lead Pipeline $455M
N/A

Pipeline of hot leads in Africa and Middle East, expected to convert soon.

Win Rate 15%
+3pp vs prior

Win rate increased from 10-12% to 15% in last three months.

Average Ticket Size $7M
Up from $1.5-5M

Average order size increasing as company pitches larger turnkey projects.

Fast read

Guidance and risk preview

Top guidance FY26 Revenue Guidance: 380-400 Cr

Management reiterated annual revenue guidance of 380-400 crore rupees, implying a strong Q4 to meet the target.

Top risk Quarterly Revenue Volatility

Shipment-based revenue recognition causes lumpy quarterly results, with ~20.3 Cr deferred from Q3 to Q4.

View Risks →